medicalxpress - Cancer doctors across the United States are running short of essential generic chemotherapy drugs, and some fear the squeeze could force widespread rationing, The New York Times reported.
AI Summary: Hospitals and oncology clinics are facing critical shortages of key chemotherapy agents, forcing clinicians to consider rationing or alternative regimens. The supply squeeze has reignited demands for federal intervention, supply‑chain fixes, and clearer contingency plans to protect patients who can’t exactly wait for bureaucratic miracles.
Hospitals push regulators to block expanded 340B claims reporting requirements / 3 months
AbbVie sues over Botox selection in Medicare price negotiations / 4 months
HHS drops 340B pilot following court rulings / 4 months
HHS scraps 340B rebate pilot following court rulls / 4 months
FTC settles insulin lawsuit forces Express Scripts policy changes / 4 months
Judge blocks 340B drug pricing pilot program implementation / 5 months
CMS Unveils Medicaid Drug Pricing Model with Most-Favored Nation Approach / 7 months
StackHealth RSS


StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.